Low-dose NOAC after COVID-19 hospitalization in patients with high thrombotic risk

3' education - Jan. 11, 2022 - Prof. Freek Verheugt, MD, PhD - Amsterdam, The Netherlands

Educational information

This video was recorded in response to the presentation of the MICHELLE trial at the ESC congress

Faculty

Prof. Verheugt - cardioloog in Amsterdam, The Netherlands.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of the MICHELLE trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.